Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1984 1
1985 3
1986 4
1987 3
1988 4
1989 4
1990 3
1991 2
1992 7
1993 10
1994 2
1995 4
1996 3
1997 5
1998 4
1999 8
2000 15
2001 21
2002 15
2003 9
2004 13
2005 10
2006 14
2007 10
2008 11
2009 11
2010 11
2011 20
2012 26
2013 15
2014 17
2015 16
2016 14
2017 12
2018 12
2019 17
2020 13
2021 8
2022 9
2023 7
2024 6
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, Kern JA, Lacouture ME. Geisler AN, et al. Among authors: kern ja. J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23. J Am Acad Dermatol. 2020. PMID: 32454097 Free PMC article. Review.
Phenotype/Immunologic Profiling in ircAEs-Response.
Goleva E, Lacouture ME, Moy AP, Kern JA, Leung DYM. Goleva E, et al. Among authors: kern ja. Clin Cancer Res. 2024 Dec 16;30(24):5694. doi: 10.1158/1078-0432.CCR-24-2949. Clin Cancer Res. 2024. PMID: 39676538 No abstract available.
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Lacouture ME, Goleva E, Shah N, Rotemberg V, Kraehenbuehl L, Ketosugbo KF, Merghoub T, Maier T, Bang A, Gu S, Salvador T, Moy AP, Lyubchenko T, Xiao O, Hall CF, Berdyshev E, Crooks J, Weight R, Kern JA, Leung DYM. Lacouture ME, et al. Among authors: kern ja. Clin Cancer Res. 2024 Jul 1;30(13):2822-2834. doi: 10.1158/1078-0432.CCR-23-3431. Clin Cancer Res. 2024. PMID: 38652814 Free PMC article.
Firearm injury: pushing forward.
Kern JA, Kaufman EJ. Kern JA, et al. Curr Opin Crit Care. 2025 Jun 1;31(3):244-251. doi: 10.1097/MCC.0000000000001262. Epub 2025 Feb 13. Curr Opin Crit Care. 2025. PMID: 40047234 Review.
HER2-targeted gene transfer.
Foster BJ, Kern JA. Foster BJ, et al. Among authors: kern ja. Hum Gene Ther. 1997 Apr 10;8(6):719-27. doi: 10.1089/hum.1997.8.6-719. Hum Gene Ther. 1997. PMID: 9113511
Sounding the mediastinum.
Kern JA. Kern JA. Am J Respir Crit Care Med. 2003 Dec 1;168(11):1261-2. doi: 10.1164/rccm.2309014. Am J Respir Crit Care Med. 2003. PMID: 14644916 No abstract available.
Immune-related cutaneous adverse events due to checkpoint inhibitors.
Wang E, Kraehenbuehl L, Ketosugbo K, Kern JA, Lacouture ME, Leung DYM. Wang E, et al. Among authors: kern ja. Ann Allergy Asthma Immunol. 2021 Jun;126(6):613-622. doi: 10.1016/j.anai.2021.02.009. Epub 2021 Feb 17. Ann Allergy Asthma Immunol. 2021. PMID: 33609771 Free PMC article. Review.
Senescence in chronic obstructive pulmonary disease.
Tuder RM, Kern JA, Miller YE. Tuder RM, et al. Among authors: kern ja. Proc Am Thorac Soc. 2012 May;9(2):62-3. doi: 10.1513/pats.201201-012MS. Proc Am Thorac Soc. 2012. PMID: 22550244 Free PMC article. Review.
Nonagenarians undergoing cardiac surgery.
Davis JP, LaPar DJ, Crosby IK, Kern JA, Lau CL, Kron IL, Ailawadi G. Davis JP, et al. Among authors: kern ja. J Card Surg. 2014 Sep;29(5):600-4. doi: 10.1111/jocs.12391. Epub 2014 Jul 8. J Card Surg. 2014. PMID: 25039683
366 results